Investigation unit
Service
Publications by the researcher in collaboration with Germán Bou Arévalo (126)
2024
-
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions
International Journal of Antimicrobial Agents, Vol. 63, Núm. 5
-
Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions” [International Journal of Antimicrobial Agents Volume 63, Issue 5 (2024) 107150] (International Journal of Antimicrobial Agents (2024) 63(5), (S0924857924000682), (10.1016/j.ijantimicag.2024.107150))
International Journal of Antimicrobial Agents
-
Dispersal history of SARS-CoV-2 in Galicia, Spain
Journal of Medical Virology, Vol. 96, Núm. 7
-
Emergence of Carbapenemase Genes in Gram-Negative Bacteria Isolated from the Wastewater Treatment Plant in A Coruña, Spain
Antibiotics, Vol. 13, Núm. 2
-
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study
Eurosurveillance, Vol. 29, Núm. 15
-
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 10, pp. 2591-2597
-
Native and non-native freshwater bivalves in the bioremediation of bacterial pollution caused by the disposal of sewage
Environmental Pollution, Vol. 360
-
Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma
Molecular Oncology, Vol. 18, Núm. 5, pp. 1143-1173
-
The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis
Molecular Oncology, Vol. 18, Núm. 5, pp. 1093-1122
2023
-
A highly-safe live auxotrophic vaccine protecting against disease caused by non-typhoidal Salmonella Typhimurium in mice
Journal of Microbiology, Immunology and Infection, Vol. 56, Núm. 2, pp. 324-336
-
A new and efficient enrichment method for metagenomic sequencing of Monkeypox virus
BMC Genomics, Vol. 24, Núm. 1
-
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain
International Journal of Antimicrobial Agents, Vol. 61, Núm. 4
-
Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1
Antimicrobial agents and chemotherapy, Vol. 67, Núm. 5, pp. e0150522
-
Building-Scale Wastewater-Based Epidemiology for SARS-CoV-2 Surveillance at Nursing Homes in A Coruña, Spain
Environments - MDPI, Vol. 10, Núm. 11
-
Comparison of the in vivo efficacy of ceftaroline fosamil, vancomycin and daptomycin in a murine model of methicillin-resistant Staphylococcus aureus bacteraemia
International Journal of Antimicrobial Agents, Vol. 62, Núm. 1
-
Diagnostic tool for surveillance, detection and monitoring of the high-risk clone K. pneumoniae ST15
Journal of Hospital Infection, Vol. 142, pp. 18-25
-
Direct Detection of Carbapenemase-Producing Klebsiella pneumoniae by MALDI-TOF Analysis of Full Spectra Applying Machine Learning
Journal of clinical microbiology, Vol. 61, Núm. 6, pp. e0175122
-
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification
International Journal of Antimicrobial Agents, Vol. 62, Núm. 4
-
Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales
Antibiotics, Vol. 12, Núm. 6
-
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 5, pp. 1195-1200